Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells
| Autor: | Florence Galtier, Henri Rochefort, Dany Chalbos, Alexandre Philips |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
medicine.medical_specialty
Transcription Genetic Polyunsaturated Alkamides medicine.drug_class medicine.medical_treatment 8-Bromo Cyclic Adenosine Monophosphate Estrogen receptor Cathepsin D Breast Neoplasms Biology Endocrinology Epidermal growth factor Internal medicine Tumor Cells Cultured medicine Humans Growth factor receptor inhibitor RNA Messenger Insulin-Like Growth Factor I Growth Substances skin and connective tissue diseases Epidermal Growth Factor Estradiol Tumor Suppressor Proteins Growth factor Estrogen Antagonists Proteins Adenosine Somatomedin Neoplasm Proteins Tamoxifen Estrogen Tetradecanoylphorbol Acetate Trefoil Factor-1 hormones hormone substitutes and hormone antagonists medicine.drug |
| Zdroj: | Endocrinology. 133:571-576 |
| ISSN: | 1945-7170 0013-7227 |
| Popis: | In MCF7 human breast cancer cells, the antiestrogens 4-hydroxy-tamoxifen and ICI 164,384 inhibit the mitogenic activity of epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I). These growth factors also stimulate the expression of cathepsin-D and pS2 genes. Therefore, we studied the effects of antiestrogens on growth factor induction of pS2 and cathepsin-D mRNA. The two antiestrogens strongly inhibited the transcriptional induction of pS2 by growth factors. On the contrary, estradiol and IGF-I or EGF had an additive effect on pS2 mRNA accumulation. Growth factor induction of cathepsin-D was also inhibited by ICI 164,384. By contrast, 4-hydroxytamoxifen had an agonist effect on cathepsin-D and an additive effect on IGF-I-induced mRNA. When 12-O-tetradecanoylphorbol-13-acetate or 8-bromo-cAMP (8-Br-cAMP) was used instead of growth factors, similar effects of 4-hydroxytamoxifen and ICI 164,384 were obtained on pS2 (12-O-tetradecanoylphorbol-13-acetate and 8-Br-cAMP) and cathepsin-D (8-Br-cAMP) induction. A mechanism based on the classical competitive inhibition by antiestrogens of estrogen binding and action on the estrogen receptor was very unlikely, as 1) no antigrowth factor activity was obtained with R5020, which was a potent inhibitor of estrogen induction of pS2 and cathepsin-D mRNA; 2) in the Ishikawa endometrial cancer cell line, the cathepsin-D gene is unresponsive to estrogen, but was inhibited by antiestrogen after its induction by EGF or 8-Br-cAMP; and 3) the residual estrogen concentration in cells was too low to induce the expression of estrogen-specific genes. However, antiestrogens did not inhibit the expression of all genes induced by growth factors, as they were without effect on IGF-I induction of glyceraldehyde-3-phosphate dehydrogenase mRNA. These results demonstrate that antiestrogens can modulate the transcription of some growth factor-induced genes and strongly suggest that this effect is not due to interference with residual estrogens. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|